P&G gets into sterols
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble signs an agreement with agribusiness and food firm Bunge Limited and manufacturer Peter Cremer for the production and marketing of phytosterol ingredients for foods and pharmaceuticals, Bunge announces Nov. 10. The alliance "creates an efficient, integrated supply chain based on Bunge's raw material supply, P&G's marketing and sales expertise and Peter Cremer's manufacturing capabilities," the firm says. Bunge estimates global demand for phytosterols will exceed 10,000 tons by 2008, representing a market value of $200-$250 mil. FDA approved the expanded use of a phytosterol CHD health claim last year (1"The Tan Sheet" Feb. 24, 2003, p. 4)...
You may also be interested in...
Phytosterol CHD Health Claim Expanded Interim Use Permitted By FDA
FDA will allow the use of a phytosterol heart health claim on a broader range of foods, beverages and dietary supplements while it completes a final rule on the issue, according to a Feb. 14 open letter posted on the agency's Web site
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.